The economic dynamics of modern biotechnology

Author(s)

Bibliographic Information

The economic dynamics of modern biotechnology

edited by Maureen McKelvey, Annika Rickne, Jens Laage-Hellman

Edward Elgar, c2004

  • : hbk
  • : pbk

Available at  / 14 libraries

Search this Book/Journal

Note

Includes bibliographical references and index

Description and Table of Contents

Description

This book offers a novel insight into the economic dynamics of modern biotechnology, using examples from Europe to reflect global trends. The authors apply theoretical insight to a fundamental enigma of the modern learning society, namely, how and why the development of knowledge and ideas interact with market processes and the formation of industries and firms. This book offers new empirical evidence to address such questions by studying the diversity of biotechnology in Europe. By analysing the way in which the development of new knowledge and information is linked with economic transformation, the authors are able to provide a rich theoretical understanding of the economic dynamics of knowledge within the biotechnology sector. They clearly show how innovation opportunities are affected not just by the market, but by scientific developments, networks, institutions and government policy. They also raise important theoretical questions about how and why new industries, networks and organizations are shaped, and highlight the development and impacts of biotechnology on many existing sectors, including pharmaceuticals, agriculture and insurance. The final chapter summarizes the theoretical challenges which have been overcome and identifies future areas for research. The Economic Dynamics of Modern Biotechnology will become essential reading for students, scholars and researchers of the management and economics of innovation, business strategy, industrial organization, the theory of the firm, the economics of technological change, and regional studies. It will also appeal to a wider political and business audience such as government policymakers and managers of biotechnology firms.

Table of Contents

Contents: Preface Part I: Introduction 1. Introduction Jens Laage-Hellman, Maureen McKelvey and Annika Rickne 2. Conceptualizing and Measuring Modern Biotechnology Johan Brink, Maureen McKelvey and Keith Smith Part II: Setting the Scene 3. Stylized Facts about Innovation Processes in Modern Biotechnology Maureen McKelvey, Annika Rickne and Jens Laage-Hellman 4. The Post-Genome Era: Rupture in the Organization of the Life Science Industry? Michel Quere 5. An Overview of Biotechnology Innovation in Europe: Firms, Demand, Government Policy and Research Jacqueline Senker Part III: Challenging the Existing 6. Risk Management and the Commercialization of Human Genetic Testing in the UK Michael M. Hopkins and Paul Nightingale 7. Network and Technology Systems in Science-driven Fields: The Case of European Food Biotechnology Finn Valentin and Rasmus Lund Jensen 8. Future Imperfect: The Response of the Insurance Industry to the Emergence of Predictive Genetic Testing Stefano Brusoni, Rachel Cutts and Aldo Geuna 9. Emergent Bioinformatics and Newly Distributed Innovation Processes Andrew McMeekin, Mark Harvey and Sally Gee Part IV: Forming the New 10. The Dynamics of Regional Specialization in Modern Biotechnology: Comparing Two Regions in Sweden and Two Regions in Australia, 1977-2001 Johan Brink, Linus Dahlander and Maureen McKelvey 11. On the Spatial Dimension of Firm Formation Annika Rickne 12. Examining the Marketplace for Ideas: How Local are Europe's Biotechnology Clusters? Steven Casper and Fiona Murray 13. Creation and Growth of High-Tech SMEs: The Role of the Local Environment Corinne Autant-Bernard, Vincent Mangematin and Nadine Massard Part V: Conclusions 14. Reflections and Ways Forward Hannah Kettler, Maureen McKelvey and Luigi Orsenigo Index

by "Nielsen BookData"

Details

Page Top